Parkinson disease, cancer, and LRRK2 Causation or association?

被引：8
|
作者：
Bandmann, Oliver [1 ]
Cookson, Mark R. [2 ]
机构：
[1] Univ Sheffield, SITraN, Dept Neurosci, Sheffield, S Yorkshire, England
[2] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
来源：
NEUROLOGY | 2012年 / 78卷 / 11期
关键词：
MUTATIONS;
D O I：
10.1212/WNL.0b013e318249f744
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：772 / 773
页数：2
相关论文
共 50 条
  • [41] Ancient origin of the Parkinson disease gene LRRK2
    Marin, Ignacio
    JOURNAL OF MOLECULAR EVOLUTION, 2008, 67 (01) : 41 - 50
  • [42] LRRK2 as a therapeutic target in Parkinson's disease
    Tan, E. K.
    Schapira, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
  • [43] Targeting LRRK2 mutations in Parkinson's disease
    Lesniak, Robert K.
    Nichols, Robert Jeremy
    Smith, Mark
    Montine, Thomas J.
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1167 - 1170
  • [44] LRRK2 and the Endolysosomal System in Parkinson's Disease
    Erb, Madalynn L.
    Moore, Darren J.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1271 - 1291
  • [45] LRRK2 in Parkinson's disease: biochemical functions
    Anand, Vasanti S.
    Braithwaite, Steven P.
    FEBS JOURNAL, 2009, 276 (22) : 6428 - 6435
  • [46] Pathological Functions of LRRK2 in Parkinson's Disease
    Jeong, Ga Ram
    Lee, Byoung Dae
    CELLS, 2020, 9 (12) : 1 - 19
  • [47] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
  • [48] LRRK2 gene in Parkinson disease -: Mutation analysis and case control association study
    Paisán-Ruíz, C
    Lang, AE
    Kawarai, T
    Sato, C
    Salehi-Rad, S
    Fisman, GK
    Al-Khairallah, T
    George-Hyslop, S
    Singleton, A
    Rogaeva, E
    NEUROLOGY, 2005, 65 (05) : 696 - 700
  • [49] Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
    C. P. Gonzalez-Hunt
    E. A. Thacker
    C. M. Toste
    S. Boularand
    S. Deprets
    L. Dubois
    L. H. Sanders
    Scientific Reports, 10
  • [50] Screening for LRRK2 mutations in patients with Parkinson's disease in Russia:: identification of a novel LRRK2 variant
    Pchelina, S. N.
    Yakimovskii, A. F.
    Emelyanov, A. K.
    Ivanova, O. N.
    Schwarzman, A. L.
    Singleton, A. B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (07) : 692 - 696
12345